Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-051303

Director sold 5,100 shares at $3.19 ($16,269)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CHESS ROBERT Director 2022-09-22 Sale −5,100 $3.19 $16,269 228,179 D: show line 1 in the form
Open-market sales · 5,100 sh · avg $3.19 · $16,269
Loading xslF345X03/doc4.xml…